| Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|
Revenues: | ||||||||
Products | ||||||||
48,727 | 54,432 | 62,642 | 77,240 | 66,318 | 77,127 | 56,810 | 40,852 | 29,641 |
Services | ||||||||
33,265 | 35,937 | 37,325 | 39,946 | 30,227 | 27,625 | 20,943 | 16,120 | 12,110 |
Total revenues | ||||||||
81,992 | 90,369 | 99,967 | 117,186 | 96,545 | 104,752 | 77,753 | 56,972 | 41,751 |
Cost of revenues: | ||||||||
Products | ||||||||
19,258 | 20,401 | 26,707 | 27,389 | 20,572 | 26,857 | 19,540 | 14,015 | 10,094 |
Services | ||||||||
9,272 | 7,494 | 6,720 | 7,350 | 6,246 | 4,180 | 2,635 | 1,970 | 1,741 |
Expenses related to settlement of OCS grants (See note 11a) | ||||||||
- | - | - | - | - | 15,886 | 0 | - | - |
Total cost of revenues | ||||||||
28,530 | 27,895 | 33,427 | 34,739 | 26,818 | 46,923 | 22,175 | 15,985 | 11,835 |
Gross profit | ||||||||
53,462 | 62,474 | 66,540 | 82,447 | 69,727 | 57,829 | 55,578 | 40,987 | 29,916 |
Operating expenses: | ||||||||
Research and development (net of grant participations of $ 392, $ 606 and $ 1,252 for the years ended December 31, 2017, 2016 and 2015, respectively) | ||||||||
21,852 | 24,221 | 26,422 | 29,014 | 27,022 | 22,060 | 13,222 | 11,264 | 9,265 |
Sales and marketing | ||||||||
38,316 | 35,290 | 43,318 | 44,599 | 39,817 | 34,127 | 26,543 | 22,021 | 20,408 |
General and administrative | ||||||||
10,696 | 9,812 | 12,702 | 11,941 | 9,952 | 10,664 | 7,474 | 5,473 | 5,541 |
Total operating expenses | ||||||||
70,864 | 69,323 | 82,442 | 85,554 | 76,791 | 66,851 | 47,239 | 38,758 | 35,214 |
Operating loss | ||||||||
-17,402 | -6,849 | -15,902 | -3,107 | -7,064 | -9,022 | 8,339 | 2,229 | -5,298 |
Financial income (expenses), net | ||||||||
894 | 1,059 | -584 | 660 | 727 | 1,358 | 415 | -7,907 | -2,311 |
Loss before income tax expense | ||||||||
-16,508 | -5,790 | -16,486 | -2,447 | -6,337 | -7,664 | 8,754 | -5,678 | -7,609 |
Income tax expense | ||||||||
1,564 | 2,204 | 3,356 | 50 | 120 | -926 | -55 | 84 | 63 |
Net loss | ||||||||
-18,072 | -7,994 | -19,842 | -2,497 | -6,457 | -6,738 | 8,809 | -5,762 | -7,672 |
Unrealized gain (loss) on available-for-sale marketable securities | ||||||||
-35 | 337 | -261 | -205 | -20 | 15 | 68 | - | - |
Unrealized gain (loss) on foreign currency cash flow hedges transactions | ||||||||
220 | -16 | 1,411 | -1,781 | -1,374 | 2,555 | -1,312 | -23 | - |
Total comprehensive loss | ||||||||
-17,887 | -7,673 | -18,692 | -4,483 | -7,851 | -4,168 | 7,565 | -5,940 | - |
Net loss per share: | ||||||||
Basic and diluted | ||||||||
-0.54 | -0.24 | -0.59 | -0.08 | -0.20 | -0.21 | - | - | - |
Basic | ||||||||
- | - | - | - | - | - | 0.35 | -0.25 | -0.35 |
Diluted | ||||||||
- | - | - | - | - | - | 0.33 | -0.25 | -0.35 |
Weighted average number of shares used in per share computations of net loss: | ||||||||
Basic and diluted | ||||||||
33,253 | 33,202 | 33,419 | 33,143 | 32,680 | 31,959 | - | - | - |
Basic | ||||||||
- | - | - | - | - | - | 25,047 | 22,831 | 22,185 |
Diluted | ||||||||
- | - | - | - | - | - | 27,071 | 22,831 | 22,185 |